BACH1 and lung carcinoma: We identified and thoroughly validated this signature as a BACH1 lung cancer “perturbation signature” that responds robustly to BACH1 inhibition or depletion; however, we did not establish whether this signature could also serve as a surrogate marker for BACH1 levels under basal (unperturbed) conditions.